leflunomide has been researched along with Kaposi Sarcoma in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current treatment of Kaposi's sarcoma is reduction of immunosuppression with or without addition of mammalian target of rapamycin inhibitors (mTORi)." | 1.37 | Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient. ( Basu, G; John, GT; Mani, SE; Manipadam, MT; Mohapatra, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, SY | 1 |
| Jo, YM | 1 |
| Chung, WT | 1 |
| Kim, SH | 1 |
| Kim, SY | 1 |
| Roh, MS | 1 |
| Lee, SW | 1 |
| Basu, G | 1 |
| Mohapatra, A | 1 |
| Manipadam, MT | 1 |
| Mani, SE | 1 |
| John, GT | 1 |
2 other studies available for leflunomide and Kaposi Sarcoma
| Article | Year |
|---|---|
Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; Leflunomide; Middle Aged; S | 2012 |
Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
Topics: Antineoplastic Agents; Everolimus; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Diseases; Ki | 2011 |